Peritonitis Carcinomatosa in a Patient with Recurrent "Superficial" Bladder Cancer Treated with Cystectomy and Nephroureterectomy

Urology

Volumn 69, Issue 1, 2007, Pages 184.e1-184.e2

  de Vries, R R ^a   Bex, A ^a   Horenblas, S ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ARTICLE; BCG VACCINATION; BLADDER CANCER; CARCINOMA IN SITU; CARCINOMATOUS PERITONITIS; CASE REPORT; COLON SURGERY; CYSTECTOMY; FEMALE; HUMAN; HUMAN TISSUE; INFRACOLIC OMENTECTOMY; LIVER BIOPSY; LIVER METASTASIS; METASTASIS; NEPHROURETERECTOMY; OVARIECTOMY; OVARY CANCER; PRIORITY JOURNAL; RECURRENT CANCER; TRANSITIONAL CELL CARCINOMA; TREATMENT FAILURE; URETER;

EID: 33846473023     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.10.002     Document Type: Article

References (10)

1. Oosterlinck W., Lobel B., Jakse G., et al. Guidelines on bladder cancer. Eur Urol 41 (2002) 105-112
2. Smith E.M., and Jayson G.C. The current and future management of malignant ascites. Clin Oncol (R Coll Radiol) 15 (2003) 59-72
3. Chrysikopoulos H., Maniatis V., Roussakis A., et al. Peritoneal metastases from transitional cell carcinoma of the urinary tract: CT and MR imaging. Abdom Imaging 23 (1998) 91-95
4. McCluggage W.G., and Wilkinson N. Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathology 47 (2005) 231-247
5. Ishii Y., Itoh N., Takahashi A., et al. Bladder cancer discovered by ovarian metastasis: cytokeratin expression is useful when making differential diagnosis. Int J Urol 12 (2005) 104-107
6. Kaufmann O., Volmerig J., and Dietel M. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas. Am J Clin Pathol 113 (2000) 683-687
7. Riedel I., Czernobilsky B., Lifschitz-Mercer B., et al. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins. Virchows Arch 438 (2001) 181-191
8. El Tabey N.A., and Shoma A.M. Port site metastases after robot-assisted laparoscopic radical cystectomy. Urology 66 (2005) 1110
9. Elbahnasy A.M., Hoenig D.M., Shalhav A., et al. Laparoscopic staging of bladder tumor: concerns about port site metastases. J Endourol 12 (1998) 55-59
10. Naderi N., Nieuwenhuijzen J.A., Bex A., et al. Port site metastasis after laparoscopic nephro-ureterectomy for transitional cell carcinoma. Eur Urol 46 (2004) 440-441